Healthy Extracts (HYEX) Cash & Current Investments (2015 - 2025)
Healthy Extracts' (HYEX) quarterly Cash & Current Investments came in at $146935.0 in Q4 2025, up 13.98% year-on-year from $128910.0 in Q4 2024, and down 22.44% quarter-over-quarter from $189452.0 in Q3 2025.
Healthy Extracts (HYEX) Cash & Current Investments (2015 - 2025) Analysis & Trends
Healthy Extracts' Cash & Current Investments history runs 11 years deep, the most recent figure standing at $146935.0 for Q4 2025.
- On a quarterly basis, Cash & Current Investments rose 13.98% year-over-year to $146935.0 in Q4 2025; TTM through Dec 2025 was $146935.0, a 13.98% increase from a year earlier, with the FY2025 full-year figure at $146935.0, up 13.98% from the prior year.
- Cash & Current Investments fell to $146935.0 in Q4 2025 per HYEX's latest filing, from $189452.0 in the prior quarter.
- Across five years, Cash & Current Investments topped out at $286939.0 in Q2 2021 and bottomed at $19441.0 in Q4 2023.
- The 5-year median for Cash & Current Investments is $123854.0 (2024), against an average of $137020.2.
- Across the five-year window, Cash & Current Investments tumbled 70.44% in 2022 and soared 563.08% in 2024, its largest moves.
- Year by year, Cash & Current Investments stood at $222098.0 in 2021, then tumbled by 70.44% to $65651.0 in 2022, then tumbled by 70.39% to $19441.0 in 2023, then surged by 563.08% to $128910.0 in 2024, then gained by 13.98% to $146935.0 in 2025.
- Per Business Quant, the three latest HYEX Cash & Current Investments figures stand at $146935.0 (Q4 2025), $189452.0 (Q3 2025), and $200494.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.86 Bn | 88.00 Bn | - | 1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 35.98 Bn | 32.24 Bn | 1.97 Bn | 3.74 Bn |
| 3 | Zoetis | 32.48 Bn | 30.54 Bn | 1.62 Bn | 1.94 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | 4.06 Bn |
| 5 | United Therapeutics | 23.01 Bn | 20.86 Bn | 648.10 Mn | 2.15 Bn |
| 6 | RedHill Biopharma | 22.02 Bn | 22.02 Bn | - | - |
| 7 | Viatris | 20.40 Bn | 18.59 Bn | 1.16 Bn | 1.80 Bn |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.46 Bn | 800.70 Mn | 1.32 Bn |
| 9 | Elanco Animal Health | 12.74 Bn | 12.31 Bn | 785.00 Mn | 428.00 Mn |
| 10 | Healthy Extracts | 14.70 Mn | 14.56 Mn | 957,429.00 | 146,935.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 146,935.00 |
| Sep 30, 2025 | 189,452.00 |
| Jun 30, 2025 | 200,494.00 |
| Mar 31, 2025 | 118,798.00 |
| Dec 31, 2024 | 128,910.00 |
| Sep 30, 2024 | 100,402.00 |
| Jun 30, 2024 | 148,231.00 |
| Mar 31, 2024 | 87,312.00 |
| Dec 31, 2023 | 19,441.00 |
| Sep 30, 2023 | 46,391.00 |
| Jun 30, 2023 | 92,501.00 |
| Mar 31, 2023 | 213,204.00 |
| Dec 31, 2022 | 65,651.00 |
| Sep 30, 2022 | 73,884.00 |
| Jun 30, 2022 | 159,405.00 |
| Mar 31, 2022 | 92,286.00 |
| Dec 31, 2021 | 222,098.00 |
| Sep 30, 2021 | 115,138.00 |
| Jun 30, 2021 | 286,939.00 |
| Mar 31, 2021 | 232,932.00 |